ORBIMED ADVISORS LLC 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-26 4:31 pm Sale |
2024-12-20 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 7,404,869 12.000% |
-629,131 (-7.83%) |
Filing |
| 2024-04-12 5:35 pm Unchanged |
2024-04-09 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 8,034,000 13.000% |
0 (Unchanged) |
Filing |
| 2023-06-29 4:36 pm Purchase |
2023-06-27 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 8,034,000 14.700% |
1,192,577 (+17.43%) |
Filing |
| 2022-05-05 4:56 pm Purchase |
2022-05-03 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 6,841,423 12.600% |
894,100 (+15.03%) |
Filing |
| 2021-01-28 1:48 pm Unchanged |
2021-01-26 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 5,947,323 11.200% |
0 (Unchanged) |
Filing |